Rights and permissions
About this article
Cite this article
All eyes on the pros and cons of vigabatrin. React. Wkly. 773, 3–4 (1999). https://doi.org/10.2165/00128415-199907730-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199907730-00005